课题基金 / 基金详情

A comparative analysis of Hsp90 and its possible role in drug resistance in nematode parasites

A comparative analysis of Hsp90 and its possible role in drug resistance in nematode parasites
Hsp90的比较分析及其在线虫耐药性中的可能作用
批准号:
BB/E013473/1
负责人:
Eileen Devaney
金额:
$55.77万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2007
资助国家:
英国
项目状态:
已结题
起止时间:
2007 至 --

项目摘要

项目成果

Eileen Devaney的其他基金

相似基金

相关文献

中文摘要
翻译
线虫寄生虫是感染人类和家畜的圆形蠕虫。它们可以在宿主中引起疾病和各种症状,并且在农场动物的经济和公共卫生方面都非常重要,特别是在世界上较贫困的地区。农场动物的线虫寄生虫的一个主要问题是耐药性的传播。有三种不同类型的药物可用于治疗受感染的动物,但一些线虫现在对所有三类药物都有抗药性。在这项研究中,我们将研究一种名为Hsp90的蛋白质是否是新药的良好靶点。这种蛋白质在癌症研究领域具有很大的意义,并且正在制备许多抑制其功能的新化合物。此外,我们将测试一个假设,热休克蛋白90也可能参与线虫的耐药性。它最近被证明是非常重要的真菌已成为抗药性,我们将研究它是否可能在线虫有类似的功能。由于有许多新的Hsp90抑制剂,这种方法可以提供逆转耐药性的潜力。
英文摘要
Nematode parasites are round worms that infect humans and domestic animals. They can cause illness and a variety of symptoms in their hosts and are very important both economically in farm animals and in public health terms, particularly in poorer areas of the world. A major problem with nematode parasites of farm animals is the spread of drug resistance. There are three different types of drugs available to treat infected animals, but some nematodes are now resistant to all three classes of drug. In this study we will investigate whether a protein called Hsp90 is a good target for new drugs. This protein is of great interest in the field of cancer research and many new compounds are being prepared which inhibit its function. In addition we will test a hypothesis that Hsp90 might also be involved in drug resistance in nematodes. It has recently been shown to be very important in fungi that have become resistant to drugs and we will investigate whether it may have a similar function in nematodes. As there are many new inhibitors of Hsp90, this approach could offer the potential to reverse drug resistance.
期刊论文(7)
专著(0)
科研奖励(0)
会议论文
Assay strategies for the discovery and validation of therapeutics targeting Brugia pahangi Hsp90.
用于发现和验证针对彭亨丝虫 Hsp90 的疗法的测定策略。
DOI: 10.1371/journal.pntd.0000714
发表时间: 2010
期刊: PLoS neglected tropical diseases
影响因子: 3.8
作者: [Taldone,Tony, Gillan,Victoria, Sun,Weilin, Rodina,Anna, Patel,Pallav, Maitland,Kirsty, O'Neill,Kerry, Chiosis,Gabriela, Devaney,Eileen]
通讯作者: Devaney,Eileen
DOI: 10.1371/journal.pntd.0002699
发表时间: 2014-02-01
期刊: PLOS NEGLECTED TROPICAL DISEASES
影响因子: 3.8
作者: [Gillan, Victoria, O'Neill, Kerry, Devaney, Eileen]
通讯作者: Devaney, Eileen
DOI: 10.1186/1471-2148-9-254
发表时间: 2009-10-22
期刊: BMC evolutionary biology
影响因子: 3.4
作者: [Him NA, Gillan V, Emes RD, Maitland K, Devaney E]
通讯作者: Devaney E
DOI: 10.1016/j.pt.2010.05.003
发表时间: 2010-09
期刊: TRENDS IN PARASITOLOGY
影响因子: 9.6
作者: [Devaney, Eileen, Winter, Alan D., Britton, Collette]
通讯作者: Britton, Collette
Development of joint research proposal (BBSRC-NSF) on the role of wildlife migration in the parasite dynamics of large herbivores
  • 批准号:
    BB/S013725/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $0.13万
  • 财政年份:
    2018
  • 负责人:
    Eileen Devaney
  • 依托单位:
The BUG consortium Building Upon the Genome: using H. contortus genomic resources to develop novel interventions to control endemic GI parasites
  • 批准号:
    BB/M003949/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $375.71万
  • 财政年份:
    2015
  • 负责人:
    Eileen Devaney
  • 依托单位:
Hsp90 as a modulator of pathogenicity, virulence and transmission in veterinary infections caused by Theileria and Babesia species
  • 批准号:
    BB/L004542/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $46.38万
  • 财政年份:
    2014
  • 负责人:
    Eileen Devaney
  • 依托单位:
国内基金
海外基金
Scalable Learning and Optimization: High-dimensional Models and Online Decision-Making Strategies for Big Data Analysis
Intelligent Patent Analysis for Optimized Technology Stack Selection:Blockchain BusinessRegistry Case Demonstration
  • 批准号:
    --
  • 项目类别:
    外国学者研究基金项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    USHARANI HAREESH GOVINDARA JAN
  • 依托单位:
利用全基因组关联分析和QTL-seq发掘花生白绢病抗性分子标记
基于SERS纳米标签和光子晶体的单细胞Western Blot定量分析技术研究
  • 批准号:
    31900571
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    24.0万元
  • 批准年份:
    2019
  • 负责人:
    刘兵
  • 依托单位: